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Induction of pluripotency in somatic cells has been achieved by myriad combinations of trans-
cription factors that belong to the core pluripotency circuitry. In this issue, Shu et al. report reprog-
ramming with lineage specifiers, lending support to the view of the pluripotent state as a fine
balance between competing differentiation forces.The induction of pluripotency in somatic
cells by transcription factors that govern
the pluripotent circuitry (Takahashi and
Yamanaka, 2006) has changed the way
that we understand pluripotency and
cellular states in general. The idea that
forced activation of master regulators
can induce lineage conversion into the
specific cell type that is controlled by
these transcription factors has become
canonical by now (reviewed in Vierbuchen
and Wernig, 2011). Since Yamanaka’s
seminal experiment, various cocktails of
transcription factors have been used for
pluripotency induction; more recently,
general epigenetic regulators that change
chromatin state through histone modi-
fications or DNA methylation have been
shown to facilitate reprogramming by
directly or indirectly activating pluripo-
tency genes (reviewed in Papp and Plath,
2013). In this issue ofCell, Shu et al. (2013)
reveal that mouse fibroblasts can be re-
programmed into induced pluripotent
stem cells (iPSCs) using nuclear factors
that control lineage specification and are
not considered to be core factors of
pluripotent stem cells.
According to the prevailing model,
pluripotency factors prohibit differentia-
tion and thereof enable the maintenance
of the undifferentiated state (Hanna
et al., 2010; Young, 2011). However, an
alternative view of pluripotency has been
suggested, according to which pluripo-
tency factors act as rival specifiers that
compete to specify differentiation along
mutually exclusive lineages (Loh and
Lim, 2011). Shu et al. now provide exper-
imental and computational support for
this idea.In their study, Shu et al. performed a
large-scale search for genes that can
replace Oct4 in the reprogramming of so-
matic cells. Their analysis demonstrates
that Gata3, as well as other mesendoder-
mal (ME) specifiers, can replace Oct4,
presumably by counteracting the upregu-
lation of ectodermal (ECT) genes induced
by Sox2. They further show that RNAi
against Dlx3, an important ECT gene,
can recapitulate this effect. Reciprocally,
they demonstrate that Gmnn, an ecto-
dermal specifier, can replace Sox2 in
reprogramming, as it attenuates the ele-
vation of ME genes induced by Oct4.
Most interestingly, reprogramming can
be achieved with Gata3 and Gmnn in the
absence of both Oct4 and Sox2. What
makes the current report so surprising is
that the combination of nuclear factors
used did not include any of the core
pluripotency factors; rather, the authors
describe the induction of pluripotency in
somatic cells by the introduction of coun-
teracting lineage specifiers.
Based on these results, the authors
propose a ‘‘seesaw’’ model that places
in the center of the reprogramming pro-
cess the balance between counteracting
differentiation cues. According to this
model, a pluripotent state can be reached
only if all specification forces are well
balanced, and such a ‘‘balanced state’’
is sufficient for reprogramming induction
in the presence of Klf4 and c-Myc. It has
been shown before that Oct4 and Sox2,
the core pluripotency activators, can
also induce lineage specification (re-
viewed in Loh and Lim, 2011). Shu et al.
take a critical step in advancing this
observation to suggest that the counter-Celleffects of pluripotency genes on differen-
tiation play a major role in the induction of
pluripotency. Furthermore, they suggest
that these effects are so critical that intro-
ducing lineage-specific nuclear factors is
sufficient to induce pluripotency. Their
model thus implies a mirror image in the
function of the pluripotency genes Oct4
and Sox2 and the lineage specifiers
Gata3 and Gmnn (Figure 1A). Therefore,
the interaction between the close cellular
states of pluripotency and early specifica-
tion may be more complex than has been
previously perceived.
Several interpretations can explain
these surprising results. First, as is advo-
cated by the authors, preventing lineage
specification into the main lineages may
by itself be sufficient for pluripotency
induction (Figure 1B, I). The fact that
RNAi against Dlx3 can replace Oct4 in
reprogramming lends support to this
idea. The balance between counteracting
differentiation cues can intuitively explain
how cells are maintained in the undiffer-
entiated state, but it is much more difficult
to speculate why such balancewould also
be sufficient for pluripotency induction.
Moreover, this interpretation does not
account for the authors’ finding that only
some, but not all, master regulators of
specification can successfully replace
Yamanaka’s reprogramming factors. The
mechanism that links specification cues
and pluripotency activation is still a ‘‘black
box’’ in the model.
An alternative explanation is that line-
age specifiers execute their role in plurip-
otency induction regardless of their main
activity in lineage specification yet not
through activation of pluripotency genes153, May 23, 2013 ª2013 Elsevier Inc. 939
Figure 1. Mechanisms by which Lineage Specifiers May Induce
Pluripotency
(A) Cooperative activation of Oct4 and Sox2 induces pluripotency, but their
discordant activation may lead to mesendodermal or ectodermal differentia-
tion, respectively. Shu et al. (2013) demonstrate that coordinate activation of
mesendodermal specifiers such as Gata3 and the ectodermal specifier Gmnn
is sufficient to induce pluripotency. Bold arrows indicate canonical activity,
whereas dashed arrows indicate noncanonical activity. Red denotes the
pluripotency state and its core transcription factors, and blue denotes the
specified states and their nuclear factors.
(B) Reprogramming somatic cells into pluripotent cells can be achieved by
induction of core pluripotency genes and can be facilitated by epigenetic
regulators, such as chromatin modifiers. The current study suggests that
pluripotency can also be induced by coordinated effects of lineage specifiers.
This induction of pluripotency can be due to: (I) coordinated inhibition of
specification; (II) a yet-undetermined mechanism that is related neither to
specification inhibition nor to activation of pluripotency genes; (III) direct
activation of core pluripotency factors by lineage specifiers; or (IV) indirect
activation of core pluripotency factors through the activation of epigenetic
regulators.(Figure 1B, II). This hypothesis
is somewhat vague, as it does
not explain how these factors
trigger pluripotency without
being wired into the pluripo-
tency network. An appealing
solution would therefore be
that some lineage specifiers
do regulate core pluripotency
factors (Figure 1B, III). The
authors provide evidence
that Gata3 is not a direct acti-
vator of Oct4; however, it may
still directly activate other plu-
ripotency factors not tested in
the current study. Further-
more, these lineage specifiers
may indirectly activate plu-
ripotency regulators through
the activation of epigenetic
regulators (Figure 1B, IV).
Such indirect activation
would be consistent with the
reprogramming kinetics pre-
sented in the study. Impor-
tantly, Gmnn, which was
used in this study as an ecto-
dermal specifier, is also
expressed in undifferentiated
pluripotent stem cells, where
it mediates the expression
of Oct4, Sox2, and Nanog
through the chromatin-re-
modeling factor Brg1 (Yang
et al., 2011). This observation
supports the notion that some
lineage specifiers may func-
tion through the core plu-
ripotency network. ChIP-seq
analyses of pluripotency-
inducing lineage specifiers
and their comparison to
pluripotency-refractory line-
age specifiers may help to
further examine these possi-
bilities.
Though the exact mecha-
nism of reprogramming by
lineage specifiers remains to
be elucidated, the suggested
model generates a novel con-
ceptual framework and raisestestable predictions. Future studies will
examine the robustness of the new
reprogramming cocktail(s) and whether940 Cell 153, May 23, 2013 ª2013 Elsevier Inthey can apply more broadly to other
settings of reprogramming and to other
cellular states. For example, previousc.work has shown that exoge-
nous Oct4 together with either
Klf4 or c-Myc is sufficient to
generate iPSCs from neural
stem cells (Kim et al., 2008);
will Gata3 and Klf4 or c-Myc
be able to reprogram neural
stem cells? Will systematic
changes in the relative levels
of Oct4 and Sox2 in pluripo-
tent stem cells correlate well
with their differentiation ten-
dencies toward different
lineages? Can direct repro-
gramming of one somatic
cell type into another be
achieved by balancing differ-
entiation cues instead of
expressing master regulators
that govern the desired cel-
lular state? The current work
raises fascinating questions
and may shift the balance of
our view of pluripotency,
from focusing mostly on the
pluripotency state to the anal-
ysis of its early differentiating
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